Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

Parkinsons NZ excited about success of living cell research

Parkinsons New Zealand excited about success of living cell research trial.

18 June 2015

Parkinsons New Zealand is excited about the results of Living Cell Technologies’ (LCT) trial involving NZ pig cells in the treatment of Parkinson’s.

New Zealand based Biotechnology Company LCT reported positive safety results in the four New Zealand patients who took part in the trial.

Dr Barry Snow, a neurologist at Auckland City Hospital who leads the research, presented the results at the 19th International Congress of Parkinson’s Disease in San Diego on Wednesday, 17 June.

“Parkinson’s New Zealand has been keenly watching this ground breaking research and we are excited about the hope these results will bring to the 10,000 Kiwis living with Parkinson’s, “says Stephanie Clare, Parkinson’s New Zealand’s Acting Chief Executive and Clinical Leader.

Dr Snow and LCT are calling NT cell therapy a success. The therapy involves implanting capsules of cells from pigs into the brains of people with well-established Parkinson’s who are experiencing a lot of problems with traditional therapy. This treatment aims to slow or stop the loss of dopamine by transplanting cells that release growth factors.

“A diagnosis of Parkinson’s can be overwhelming and we don’t want anyone to face Parkinson’s alone,” says Stephanie. “Right now somewhere in New Zealand someone is being told they have Parkinson’s and I want to make sure they know our Community Educators and Parkinson’s New Zealand will be there to support them, provide information, referrals and exercise and support groups to help them live well with Parkinson’s.”

Parkinson’s is a progressive neurodegenerative condition. It is caused by insufficient quantities of dopamine - a chemical in the brain. Dopamine enables quick, well-coordinated movement. When dopamine levels fall, movements become slow and awkward. Parkinson’s has both motor and non-motor symptoms, and while it cannot be cured it can be treated.

ends

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
GenPro: General Practices Begin Issuing Clause 14 Notices

GenPro has been copied into a rising number of Clause 14 notices issued since the NZNO lodged its Primary Practice Pay Equity Claim against General Practice employers in December 2023.More

SPADA: Screen Industry Unites For Streaming Platform Regulation & Intellectual Property Protections

In an unprecedented international collaboration, representatives of screen producing organisations from around the world have released a joint statement.More

 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.